Epidemiological profile of nosocomial infection in patients treated in a high–complexity clinic from Medellin city
Main Article Content
Abstract
Objective: To make an epidemiological characterization of nosocomial infections in a high-complexity clinic in the city of Medellin.
Methodology: Observational descriptive study with a sample of 1712 patients, who presented nosocomial infection. The quantitative variables were analyzed by means of measures of central tendency, dispersion and position; in turn, the qualitative variables were presented with absolute and relative frequencies.
Results: The rate infection was 4.3%; 67.5% occurred in adults. There was a continuous decrease in rate infection from 2010 to 2015 of 35.4%. Surgical site infection was the most common infection with 29%, followed by bacteremia (21%), urinary tract infection (18%) and pneumonia (16%). Adult intensive care unit was the service that showed a greater decrease in the rate of infections reducing from 15% in 2012 to 8% in 2015. Escherichia coli was the most isolated microorganism, followed by Staphylococcus aureus and Klebsiella sp.
Conclusions: The data collected evidenced that a proper infection control program is essential in improving the quality of patient care.
Article Details
References
CDC/NHSN. Surveillance definition of healthcare-associated infection and criteria for specific types of infections in the acute care setting. Atlanta, 2010
Alleganzi B, Bagheri S, Combescuri C, Graafman W, Attar H, Donaldson L, et al. Burden of endemic health-care-asociated infection in developing countries: Systematic reveiw and meta-analysis. Lancet. 2011; 377(9761):228-41
Rosenthal VD, Maki DG, Mehta Y, Leblebicioglu H, Memish ZA, Al-Mousa HH, et al. International nosocomial infection control consortium (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module. Am J Infect Control. 2014; 42(9):942-56.
Zarb P, Coignard B, Griskeviciene J, Muller A, Vankerckhoven V, Weist K, et al. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Euro Surveill. 2012; 17(46):10.2807/ese.17.46.20316-en.
Aranaz-Andrés JM, Aibar-Remón C, Limón-Ramírez R, Amarilla A, Restrepo FR, Urroz O, et al. [IBEAS design: Adverse events prevalence in Latin American hospitals]. Rev Calid Asist Organo. 2011; 26(3):194-200.
Pujol M, Limón E. Epidemiología general de las infecciones nosocomiales. Sistemas y programas de vigilancia. Enfermedades Infecc Microbiol Clínica. 2013; 31(2):108-13.
Deptuła A, Trejnowska E, Ozorowski T, Hryniewicz W. Risk factors for healthcare-associated infection in light of two years of experience with the ECDC point prevalence survey of healthcareassociated infection and antimicrobial use in Poland. J Hosp Infect. 2015; 90(4):310-5.
Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis. 2003; 36(5):592-8.
Lossa GR, Lerena RG, Fernández LE, Vairetti J, Díaz C, Arcidiácono D, et al. Prevalence of hospital infections in adult intensive care units in Argentina. Rev Panam Salud Pública. 2008; 24(5):324-30.
Secretaría Distrital de Salud de Bogotá D.C. Boletín epidemiológico de infecciones intrahospitalarias año 2010. 2011.
Eriksen HM, Iversen BG, Aavitsland P. Prevalence of nosocomial infections in hospitals in Norway, 2002 and 2003. J Hosp Infect. 2005; 60(1):40-5.
CDC/NHSN. Report, data summery for 2010, device-associated module. Division of healthcare quality promotion. 2010.
Dudeck MA, Weiner LM, Allen-Bridson K, Malpiedi PJ, Peterson KD, Pollock DA, et al. National Healthcare Safety Network (NHSN) report, data summary for 2012, Device-associated module. Am J Infect Control. 2013; 41(12):1148-66.
Lin K-Y, Cheng A, Chang Y-C, Hung M-C, Wang J-T, Sheng W-H, et al. Central line-associated bloodstream infections among critically-ill patients in the era of bundle care. J Microbiol Immunol Infect. 2017; 50(3):339-348.
Berg TC, Kjørstad KE, Akselsen PE, Seim BE, Løwer HL, Stenvik MN, et al. National surveillance of surgical site infections after coronary artery bypass grafting in Norway: Incidence and risk factors. Eur J Cardio-Thorac Surg. 2011; 40(6):1291-7.
Careaga G, Aguirre GG, Medina LE, Borrayo G, Prado G, Argüero R. Factores de riesgo para mediastinitis y dehiscencia esternal después de cirugía cardíaca. Rev Esp Cardiol. 2006; 59(2):130 5.
Sjögren J, Malmsjö M, Gustafsson R, Ingemansson R. Poststernotomy mediastinitis: A review of conventional surgical treatments, vacuum-assisted closure therapy and presentation of the Lund University Hospital mediastinitis algorithm. Eur J Cardio-Thorac Surg. 2006; 30(6):898-905.
Rosenthal VD, Richtmann R, Singh S, Apisarnthanarak A, Kübler A, Viet-Hung N, et al. Surgical site infections, International Nosocomial Infection Control Consortium (INICC) report, data summary of 30 countries, 2005-2010. Infect Control Hosp Epidemiol. 2013; 34(6):597-604.
Silva LE, Buitrago AF, Maldonado J, Gómez M, Rendón I, Restrepo J, et al. Tasa de infección en el sitio operatorio en cirugía de revascularización miocárdica en la Fundación Santa Fe de Bogotá. Rev Colomb Cardiol. 2011; 18(1):151-61.
Lowman W. Active surveillance of hospital-acquired infections in South Africa: Implementation, impact and challenges. South Afr Med J. 2016; 106(5):489-93.
OMS. Alianza mundial para la seguridad del paciente. La investigación en seguridad del paciente. Mayor conocimiento para atención más segura. World Health Organization, Ginebra, 2008.
Anderson DJ, Podgorny K, Berríos-Torres SI, Bratzler DW, Dellinger EP, Greene L, et al. Strategies to prevent surgical site infections in acute care hospitals: 2014 Update. Infect Control Hosp Epidemiol. 2014; 35(6):605-27.
Lepelletier D, Bourigault C, Roussel JC, Lasserre C, Leclère B, Corvec S, et al. Epidemiology and prevention of surgical site infections after cardiac surgery. Médecine Mal Infect. 2013; 43(10):403-9.
Hogle NJ, Cohen B, Hyman S, Larson E, Fowler DL. Incidence and risk factors for and the effect of a program to reduce the incidence of surgical site infection after cardiac surgery. Surg Infect. 2014; 15(3):299-304.
Nyamogoba H, Obala AA. Nosocomial infections in developing countries: Cost effective control and prevention. East Afr Med J. 2002; 79(8):435-41.
Ministerio de Sanidad y Consumo. Plan de calidad para el sistema nacional de salud. Estudio nacional sobre los efectos adversos ligados a la hospitalización (ENEAS). Madrid, febrero: 2006.
Reilly J, Cairns S, Fleming S, Hewitt D, Lawder R, Robertson C, et al. Results from the second Scottish national prevalence survey: The changing epidemiology of healthcare-associated infection in Scotland. J Hosp Infect. 2012; 82(3):170-4.
Morales C, Guanche H, Núñez L, Fresneda G, Gutiérrez F. Sensibilidad de los sistemas de vigilancia de las infecciones nosocomiales. Rev Cuba Enferm. 2004;2 0(2):1-1.
